ACC 2024

The Andrew DeFilippis Lab had an exceptional weekend at the American College of Cardiology 2024 conference in Atlanta, GA! Dr. Andrew DeFilippis presented fascinating insights from the MINT Trial, delving into the debate between Restrictive vs. Liberal Transfusions in patients with Type 1 or Type 2 myocardial infarction. Meanwhile, Dr. Kárita Lidani shared compelling findings from her research with the MESA study, exploring circulating levels of angiotensinogen, sex, and hormone therapy. Being part of the stimulating discussions at ACC 2024 was truly an honor. Looking forward to the impactful collaborations ahead!

Submitted by bierens on